The Latest Breaking News from Viridian

Viridian is set to come out in June.

Over the last two weeks, TerrAscend (OTC: TRSSF), Verano (OTC: VRNOF), and Acreage (OTC: ACRDF) have obtained new credit agreements with interest rates in the low teens, demonstrating tha

Gritstone bio (NASDAQ:GRTS) announced that interim results from the Phase 1/2 trial of GRANITE, its individualized, vaccine-based immunotherapy candidate for solid tumor cancers, were published today in Nature Medicine. The initial results from the study are expected during second half of 2023. Gritstone shares traded in a range of $3.96 to $4.24…

Lowered valuations for cannabis companies are leading to a shift in the way capital is raised and merger and acquisition activity is occurring in the cannabis space. In this context, cannabis investors can leverage their understanding of M&A to anticipate corporate strategic moves and profit.